Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nicola Verna is active.

Publication


Featured researches published by Nicola Verna.


International Journal of Immunopathology and Pharmacology | 2006

Cobalt nano-particles modulate cytokine in vitro release by human mononuclear cells mimicking autoimmune disease

Claudia Petrarca; Angela Perrone; Nicola Verna; Fabio Verginelli; Ponti Jessica; E. Sabbioni; Di Giampaolo Luca; V D'adorante; Cosima Schiavone; P. Boscolo; R Mariani Costantini; M. Di Gioacchino

: The use of particles from micro to nanoscale provides benefits to diverse scientific fields, but because a large percentage of their atoms lie on the surface, nanomaterials could be highly reactive and pose potential risks to humans. Due to their wide range of application, Cobalt nano-particles are of great interest both in industry and in life-science. To date, there are few studies on Co nano-particle toxicology. In this respect, this study aims at evaluating in vitro the potential interference of Co nano-particles on the production of several cytokines (IL-2, IL-4, IL-6, IL-10, IFNgamma and TNFalpha) by PBMCs, comparing their effects to those of Co micro-particles and Co solution (CoCl2). Cells were cultured in Opticell flasks with escalating concentrations (10-5, 10-6 and 10-7 M), of Co nano and micro-particles and CoCl2 or without metal. Cytokines were quantified in the supernatants using a human Th1/Th2 cytokine cytometric bead array. Co micro-particles showed a greater inhibitory effect compared to other Co forms. Its inhibitory activity was detected at all concentrations and towards all cytokines, whereas Co solutions selectively inhibited IL-2, IL-10 and TNF-alpha at maximal concentration. Co nano-particles induced an increase of TNF-alpha and IFN-gamma release and an inhibition of IL-10 and IL-2: a cytokine pattern similar to that detected in the experimental and clinical autoimmunity. On the basis of the obtained data, immune endpoints should be sought in the next series of studies both in vitro and in vivo in subjects exposed to cobalt nano-particles.The mainstay of therapy for patients with advanced prostate cancer still remains androgen deprivation, although response to this is invariably temporary. Most of the patients develop hormone-refractory disease resulting in progressive clinical deterioration and, ultimately, death. Until recently there has been no standard chemotherapeutic approach for hormone refractory prostate cancer (HRPC), the major benefits of chemotherapy being only palliative. The studies combining mitoxantrone plus a corticosteroid demonstrated that chemotherapy could be given to men with symptomatic HRPC with minimal toxicity and a significant palliation could be provided. Recently, results from 2 phase III randomized clinical trials demonstrating that a combination of docetaxel plus prednisone can improve survival in men with HRPC have propelled docetaxel-based therapy into the forefront of treatment options for these patients as the new standard of care. There is a promising activity of new drug combinations such as taxanes plus vinca alkaloids; bisphosphonates are assuming a prominent role in prostate therapy through their ability to prevent skeletal morbidity. Combinations of classic chemotherapeutic agents and biological drugs began to be tested in phase II-III trials and the first results appear interesting. This article focuses on combinations recently evaluated or under clinical development for the treatment of HRPC.


Contact Dermatitis | 2000

Lymphocyte subset changes in blood and gastrointestinal mucosa after oral nickel challenge in nickel‐sensitized women

Mario Di Gioacchino; P. Boscolo; E. Cavallucci; Nicola Verna; Fabio Di Stefano; Maria Bernadette Di Sciascio; Silvio Masci; M. Andreassi; E. Sabbioni; Domenico Angelucci; Pio Conti

This study investigates lymphocyte subsets in both the gastrointestinal mucosa and blood, in patients with nickel allergic contact dermatitis, after 10 mg oral nickel challenge (double‐blind, placebo‐controlled). 6 such patients with cutaneous symptoms induced only by skin contact with nickel (group A), 6 with a flare‐up of cutaneous symptoms after food nickel ingestion (group B) and 6 healthy controls (group C) were enrolled. Blood lymphocyte subsets (CD4, CD45RO, CD8) were analyzed before and after 4 and 24 h from the challenge (test 1, 2, and 3), and intestinal biopsies were performed 2 days later. Challenges were positive in group B and negative in group A and controls. Serum and urine nickel levels significantly increased after nickel ingestion, with no differences between the 3 groups. At test 3, a significant decrease of the all CDs studied was found in group B. Biopsies of this group showed higher levels of CD45RO+ cells in the lamina propria and in the epithelium and lower levels of epithelial CD8+ lymphocytes. This study confirms that ingested nickel may induce flare‐up of cutaneous reactions in some nickel‐allergic patients, independently of the degree of sensitization and the intake of metal. In these patients, oral nickel stimulates the immune system, inducing maturation of T lymphocytes from virgin into memory cells; these latter cells seem to accumulate in the intestinal mucosa. The immunoreaction also involves CD8+ cells, whose role is not yet clear.


International Journal of Immunopathology and Pharmacology | 2002

Steroid and antihistamines modulate RANTES release in cultured peripheral blood mononuclear cells of atopic patients.

M. Di Gioacchino; Nicola Verna; E. Cavallucci; F. Paolini; R. Caruso; M. Grana; Cosima Schiavone; A. Di Iorio; S. Ramondo; Marcella Reale; R. Paganelli; Theoharis C. Theoharides

RANTES plays a crucial role in cell recruitment in allergic inflammation. We investigated the pharmacological modulation of RANTES release in cultured peripheral blood mononuclear cells obtained from allergic patients with active asthma. Chemokine production was assessed before and after 15 day treatment with histamine-1 receptor antagonists (Loratadine or Cetirizine) and a steroid (Deflazacort), both in unstimulated and PHA-stimulated cell cultures. Results were compared with those obtained from placebo-treated patients. During the treatment period, patients recorded morning and evening peak expiratory flow (PEF) by mini-Wright. PEF absolute values and diurnal variability significantly improved respect to the pre-treatment in steroid-treated patients, in comparison to the placebo and antihistamine-treated groups (p<0.001 and 0.01, respectively). PEF diurnal variability in the antihistamine-treated group were lower than placebo-treated group without statistical significance (p=0.06). No differences could be found in RANTES levels in supernatants of all cultures between the two antihistamines. RANTES release significantly decreased in supernatants of all cell cultures from steroid (p<0.01) and antihistamine (p=0.03 and 0.04) groups after treatments, compared to the basal values; whereas it increased slightly in controls. Co-variance analysis on RANTES levels, adjusting for pre-treatment values, showed a significant reduction of RANTES release by PHA-stimulated PBMCs from steroid (p=0.003) and anti-histamine (p=0.03) groups, with respect to the placebo group. The same statistical tool applied between the steroid and the antihistamine groups showed, after therapy, the lowest levels of RANTES to be associated with steroid treatment (p=0.005). The study shows that steroid is the most effective drug in modulating RANTES release from PBMCs. However, antihistamines, which are able to reduce cell recruitment due to chemokine release, avoiding important side effects, may be useful in long term therapy in controlling and preventing allergic inflammation.


International Journal of Immunopathology and Pharmacology | 2007

Immunotoxicity and Sensitizing Capacity of Metal Compounds Depend on Speciation

M. Di Gioacchino; Nicola Verna; L Di Giampaolo; F Di Claudio; M.C. Turi; Angela Perrone; Claudia Petrarca; Renato Mariani-Costantini; E. Sabbioni; P. Boscolo

Immunotoxicity of metal compounds is an issue of great importance due to the recent industrial application of metals with unknown toxicity on the immune system and the discovery of metal intermediary compounds not sufficiently studied yet. In this report we show results of our study on the immunotoxicity of the following metals: the Platinum group elements (Platinum, Palladium, Rhodium), Titanium and Arsenic. We applied functional and non functional assays and investigated both innate and adaptive immune systems, in particular, cell proliferation, cytokine production by PBMCs and O−2 production by neutrophils. We obtained the following results: only some Ti compounds (Titanocene, Ti ascorbate and Ti oxalate) show immunotoxicity. Trivalent As compounds (Sodium arsenite and tetraphenyl arsonium chloride) are more immunotoxic than the other investigated As compounds. Genotoxicity of Pt group compounds is in the following order: Pt < Rh < Pd. Immunotoxicity of Pt group compounds is in the following order: Pd < Pt < Rh. Lymphocytes and macrophages show a different reaction of neutrophils to metal toxicity. We can conclude that these studies show that metal immunotoxicity depends on speciation. In general speciation provides additional and often essential information in evaluating metal toxicity. However, there are many difficulties in applying speciation in investigating toxico-kinetic aspects to many metals, mainly due to the lack of information about the existence and significance of species and to the lack of analytical methods for measuring species in biological samples.


Thorax | 2007

Occupational eosinophilic bronchitis in a foundry worker exposed to isocyanate and a baker exposed to flour

Fabio Di Stefano; Luca Di Giampaolo; Nicola Verna; Mario Di Gioacchino

Eosinophilic bronchitis without asthma may occur as a consequence of occupational exposure. The cases of a foundry worker and a baker who developed symptoms, respectively, due to exposure to isocyanate and flour, are reported. Cough was not associated with variable airflow obstruction or with airway hyper-responsiveness and was responsive to inhaled corticosteroids. The eosinophilia detectable in their sputum was causally related to the occupational exposure in the workplace. The examination of induced sputum should be used in addition to the objective monitoring of lung function for workers who have asthma-like symptoms in an occupational setting.


International Journal of Immunopathology and Pharmacology | 2004

Immune effects of nickel.

Felice Salsano; C. Francia; I. Roumpedaki; M. Proietti; S. Pisarri; Nicola Verna; E. Gabriele; G. Di Gioacchino; M. Di Gioacchino

Data on nickel immunomodulation are contradictory. The most consistent immune effects are suppression of immune responses. It has been show that T-lymphocytes and NK cells are more susceptible to nickel toxicity than are B lymphocytes or macrophages. Data reported about cytokine production in human and nickel reactive T-cell clones are also conflicting. Some authors studied cytokine production PBMC cultures of nickel allergic individuals after stimulation with NiSo4. They showed a higher synthesis of IL4, IL5 and IL13 but not of IFN gamma and TNFα in Ni allergic subjects. We found that the addiction of NiSo4 to the PBMC cultures of non sensitised subjects induces a reduction of release of IL5, IFN γ and TNFα. Our studies demonstrate a clear difference in NK cell activity between nickel-tolerant and intolerant individuals. In particular NK cell activity in reduced in sensitised patients respect to the normal subjects and the addition of Ni to the PBMC cultures induce a significant decrease of NK cell activity. The decrease was greater in cell derived from allergic subjects than non allergic. In conclusion, reported data show Ni has immunotoxic potential. Researches are in progress in an attempt to correlate the present data with other immune parameters and to measure the effects of a Ni free diet on the immune system of subjects with Ni intolerance. The comprehension of the mechanisms inducing these changes requires further studies in the uptake and intracellular distribution and binding of the metal.


Allergy | 2002

Probiotics and food-allergic diseases

Roberto Paganelli; S. Ciuffreda; Nicola Verna; E. Cavallucci; F. Paolini; S. Ramondo; M. Di Gioacchino

The definition of probiotics is always evolving, since it includes natural live micro‐organisms, cellular subfractions, as well as genetically engineered derivatives or proteins. The scope of probiotic administration is beneficial change of the intestinal microflora, and improvement of non immune or immune resistance in the intestinal tract. Very few controlled human studies have been reported, but many in vitro and experimental animal studies point to their safety and potentially useful applications. We shall review the published reports and discuss mainly the prospective uses in the field of allergic diseases, with reference to the implication of the natural (innate) immune system as regulator of the development of abnormal responses to ingested food antigens.


Allergy | 2000

Influence of total IgE and seasonal increase of eosinophil cationic protein on bronchial hyperreactivity in asthmatic grass‐sensitized farmers

M. Di Gioacchino; E. Cavallucci; F. Di Stefano; Nicola Verna; S. Ramondo; S. Ciuffreda; Graziano Riccioni; P. Boscolo

Background: This study correlates biomarkers of atopy (serum total and specific IgE) and inflammation (serum eosinophil cationic protein) with bronchial hyperreactivity assessed after the complete end of pollination, in a group of farmers suffering from grass‐allergic asthma.


Journal of Occupational Health | 2003

Cavitating BOOP Associated with Myeloperoxidase Deficiency in a Floor Cleaner with an Incidental Heavy Exposure to Benzalkonium Compounds

Fabio Di Stefano; Nicola Verna; Luca Di Giampaolo; P. Boscolo; Mario Di Gioacchino

Bronchiolitis Obliterans Organizing Pneumonia (BOOP) is an inflammatory lung disease simultaneously involving the terminal bronchioles and alveoli. BOOP is defined idiopathic in most patients, but it can also be secondary to several known causes (drugs, infections, organ transplantation, radiotherapy) or associated to tumours and haematologic malignancies, rheumatologic and connective tissue diseases, immunodeficiency syndromes, inflammatory bowel diseases and other systemic disorders . Rarely BOOP has been reported as related to occupational or environmental agents exposure. We describe a lady developing BOOP two weeks after she inhaled vapours of benzalkonium compounds, components of a cleaning agent a lot which was spilled on the floor.


Immunobiology | 2000

Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis.

Mario Di Gioacchino; E. Cavallucci; Maria Bernadette Di Sciascio; Fabio Di Stefano; Nicola Verna; Lucio Lobefalo; Clorinda Crudeli; Anna Rita Volpe; Domenico Angelucci; F. Cuccurullo; Pio Conti

We assessed the infiltration of CD45RO+ cells in conjunctival biopsies of fifteen subjects affected by seasonal allergic conjunctivitis by means of immunohistochemistry. Correlations between infiltration of CD45RO+ cells and serum and mucosal indices of eosinophilic activation were investigated. The study was performed in autumn and all selected patients showed <<red eyes>> also in absence of sensitising pollens. Fifteen healthy subjects were used as controls. The semi-quantitative count of CD45RO+ cells in biopsy specimens demonstrated that positive cells were higher in allergic patients than in controls (p < 0.001) and EG2+ eosinophils were present only in biopsies of allergic patients. Furthermore, a statistically significant positive correlation (r = 0.73; p < 0.001) between CD45RO+ lymphocytes and EG2 positive eosinophils, was observed in the biopsies of allergic patients. Total serum IgE significantly correlated with CD45RO+ cells (r = 0.61; p < 0.02) and EG2+ eosinophils (r = 0.67; p < 0.01) in the conjunctiva. On the other hand serum ECP did not correlate with any histological and immunohistochemical parameters in the conjunctival biopsies. The present study shows that mild symptoms in SCA patients out of pollen season are associated with inflammation of the conjunctiva as shown by an increased number of CD45RO and EG2 positive cells.

Collaboration


Dive into the Nicola Verna's collaboration.

Top Co-Authors

Avatar

P. Boscolo

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

M. Di Gioacchino

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

Mario Di Gioacchino

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

E. Cavallucci

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

Fabio Di Stefano

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

Roberto Paganelli

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Pio Conti

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

S. Ramondo

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

Cosima Schiavone

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

F. Paolini

University of Chieti-Pescara

View shared research outputs
Researchain Logo
Decentralizing Knowledge